Kenneth Zucker: The Psychologist Gender Activists Tried to Silence (#31)
For European clinicians and policymakers grappling with the fallout of two decades of affirmation-only practice, Kenneth Zucker's account of how gender medicine transformed from careful developmental assessment into ideological orthodoxy is essential listening. His long-run data on desistance rates and the measurable consequences of early social transition bear directly on the debates now playing out from Stockholm to Amsterdam to Brussels.
Kenneth Zucker spent forty years running the Gender Identity Service at Toronto's Centre for Addiction and Mental Health, and shaped the diagnostic language the entire world has used. He chaired the work group that produced the DSM-5's sexual and gender identity disorders chapter, and contributed to DSM-3R and DSM-4 as well. When clinicians in the Netherlands developed the Dutch protocol in the 1990s, when Sweden's Karolinska opened its paediatric gender service, or when German professional bodies debated diagnostic criteria, they were working, in large part, with the framework Zucker had helped build. In 2015, after four decades of careful, research-led work, Zucker's clinic was shut following a campaign by gender-identity activists who accused him of practising conversion therapy. He sued, won a settlement of approximately 800,000 dollars, and received a public apology. European clinicians who have faced similar accusations — Dutch psychologists, Swedish researchers, French psychiatrists — will recognise the political mechanism at work: the reframing of evidence-based watchful waiting as a form of harm, and the effective silencing of dissent within institutions. Central to this conversation is the desistance question. In Zucker's Toronto clinic, where children were assessed carefully over time rather than immediately affirmed, roughly eighty percent of gender-dysphoric children came to identify with their birth sex by adolescence, and many turned out to be gay or lesbian. When children undergo early social transition, that figure inverts: only around twelve percent subsequently desist. This data point carries enormous weight for countries like Sweden and Finland, which have moved away from affirmation-only approaches and placed watchful waiting back at the centre of their clinical guidance. Zucker also discusses new research by Christina Olson showing that eighty-eight percent of socially transitioned children persist in a cross-sex identity, compared to twelve percent in his Toronto sample. The contrast does not mean persistence is inherently wrong, but it demonstrates that early social transition is not a neutral clinical step. It changes outcomes, substantially and probably durably. For EU policymakers and national health authorities in the Netherlands, Germany and France still deliberating on clinical standards, these are among the most consequential findings in recent gender medicine research. The episode examines the internal contradictions of WPATH, the body whose Standards of Care have served as a de facto global benchmark, including across European healthcare systems. Zucker notes that WPATH simultaneously frames gender diversity as natural human variation requiring no medical explanation and as a condition requiring medical intervention. This contradiction had practical consequences: it made critical scrutiny of treatment politically difficult and provided cover for what he describes as the shift from careful assessment to treatment on demand. European clinical bodies that deferred to WPATH guidelines are now living with the results. For European listeners, what this conversation offers above all is historical grounding. The arc from 1975 to the present — from Zucker's founding clinic to the dismissal of cautious clinicians across multiple countries, and now to the reassessments emerging in Stockholm, Helsinki and beyond — is a single continuous story. Understanding how political pressure displaced clinical judgment, and what the evidence actually shows, is the necessary starting point for rebuilding genuinely evidence-based care for gender-distressed young people across the continent.
